Articles
A Real-World, Prospective, Comparative Study of Postoperative Chair Time for Advanced Technology IOLs
- Journal/Conference:
- AAO 2025
- Author(s):
- Modi SS, Melendez RF, Davidorf J, Baker Z, Vartanian M, Dhariwal M, Ainslie-Garcia MH, Kambli A, Bhandari P, Shokoohi M
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Other
- Condition:
- Eye
Ranking the Importance of Prognostic Factors for Relapsed/Refractory Multiple Myeloma: International Physician Panel Consensus Following a Systematic Literature Review
- Journal/Conference:
- Clin Lymphoma Myeloma Leuk
- Author(s):
- Shaji Kumar, Xavier Leleu, Katja C Weisel, Rakesh Popat, Beatrice Suero, Samantha Craigie, Paul Spin, Leena Patel, Abril Oliva Ramirez, Christian Hampp, Wenzhen Ge, Qiufei Ma, Sundar Jagannath
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Hematology, Oncology
- Condition:
- Relapsed or Refractory Multiple Myeloma
Canadian real-world hybrid longitudinal cohort study of treatment discontinuations and modifications for patients with HER2+ and HER2-low metastatic breast cancer on trastuzumab deruxtecan enrolled in a patient support programme: the HER-TEMPO study protocol
- Journal/Conference:
- BMJ Open
- Author(s):
- Christine Brezden-Masley, Rana Qadeer, Zhor Senhaji Mouhri, Bianca Salvo, Nicolle Bonar, Paul Spin, Simran Shokar
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Oncology
- Condition:
- Breast Cancer
Cost-effectiveness of insulin icodec for the treatment of type 2diabetes in Canada
- Journal/Conference:
- J Med Econ
- Author(s):
- David A. Garcia , Godfrey Mau, Sumeet Singh, Michaela Spence, Morten Sall Jensen and Ronald Goldenberg
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Metabolic
- Condition:
- Diabetes/Endocrine/Metabolic Disorders
Global Societal Burden of Alzheimer’s Disease by Severity: a Targeted Literature Review
- Journal/Conference:
- Neurology and Therapy
- Author(s):
- Cavaco, M.A., Jang, S.R., Olsen, C., Bodnar, C., Ferko, N.
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Neurology
- Condition:
- Alzheimer's Disease
Network Meta-analysis of 1.5% Ruxolitinib Cream Versus Systemic Agents in the Treatment of Moderate Atopic Dermatitis
- Journal/Conference:
- Dermatology and Therapy
- Author(s):
- Melinda J. Gooderham, H. Chih-ho Hong, Di Wang, Becky Hooper, Avery Hughes-Martin, Heather Cameron, Laura Pastor, Alicia Pepper, Ping Wu, Ali Mojebi, Grace Wong, Rafael Marino, Marie-Lise Dion & Mehdi Larbi
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Immunology
- Condition:
- Atopic Dermatitis
Cost-effectiveness Analysis of Biosimilar Denosumab for the Treatment of Women with Post-menopausal Osteoporosis in the United States: A Risk Based Analysis
- Journal/Conference:
- ACR
- Author(s):
- Li E, McTavish R, Mirzayeh Fashami F, Kane S, Schauf M
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Musculoskeletal
- Condition:
- Osteoporosis
Cost-effectiveness analysis of somapacitan-beco versus somatropin in the treatment of patients with pediatric growth hormone deficiency (GHD) in the United States
- Journal/Conference:
- AMCP Nexus
- Author(s):
- Tindal, M, Li, E, Mehl, A, Srivastava, A.
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Metabolic
- Condition:
- Growth Hormone Deficiency
Mission impossible? Caveats in interpreting and comparing long-term efficacy in biologic studies for moderate-to-severe plaque psoriasis
- Journal/Conference:
- JEADV
- Author(s):
- Langley RG, Egeberg A, Gooderham M, Bissonnette R, Ringuet J, Kalia S, Park-Wyllie L, Abbarin N, Tran D, Zara A, Yang YW, Strober B.
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Immunology
- Condition:
- Psoriasis
A Matching-Adjusted Indirect Comparison of Guselkumab and Secukinumab in Patients with Psoriatic Arthritis Over 52 Weeks.
- Journal/Conference:
- Rheumatol Ther
- Author(s):
- Van Sanden S, Schubert A, Patel BP, Zimmermann M, Hassan F
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Immunology, Musculoskeletal
- Condition:
- Psoriatic Arthritis